Estimates Revisions Beximco Pharmaceuticals PLC. London S.E.
Stocks
BXP
US0885792061
Pharmaceuticals
|
Market Closed -
London S.E.
11:35:19 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 57.50 GBX | 0.00% |
|
-4.17% | +35.29% |
| 09-15 | Beximco Pharmaceuticals Confirms Reports of Potential Board Changes | MT |
| 06-26 | Beximco suspension lifted; M1 payment date extension | AN |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Beximco Pharmaceuticals PLC.(BXPHARMA)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Beximco Pharmaceuticals PLC.(BXPHARMA)
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Beximco Pharmaceuticals PLC.(BXPHARMA)
EBIT
Dividend / Share (DPS)
Data source:
Beximco Pharmaceuticals PLC.(BXPHARMA)
- Stock Market
- Stocks
- BXPHARMA Stock
- BXP Stock
- Consensus Beximco Pharmaceuticals PLC.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
